NCT02341326View on ClinicalTrials.gov

Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD

CompletedOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 29, 2024

Study Completion Date

October 29, 2024

Conditions
COPDSmokingLung Disorder
Trial Locations (1)

10021

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT02341326 - Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD | Biotech Hunter | Biotech Hunter